dinaline has been researched along with Cancer of Colon in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Haberkorn, U; Petru, E; Schaider, H | 1 |
| Berger, MR; Haberkorn, U; Morr, I; Oberdorfer, F; Schaider, H; van Kaick, G | 1 |
| Berger, MR; Seelig, MH | 1 |
| Corbett, TH; Foster, BJ; Jones, L; LoRusso, PM; Wiegand, R | 1 |
| Lelieveld, P; Middeldorp, RJ; van Putten, LM | 1 |
5 other study(ies) available for dinaline and Cancer of Colon
| Article | Year |
|---|---|
Combination treatment based on metabolic effects of dinaline.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Glucose; Humans; Phenylenediamines; Tumor Cells, Cultured | 1995 |
Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.
Topics: Aminoisobutyric Acids; Antineoplastic Agents; Carbon Radioisotopes; Colonic Neoplasms; Deoxyglucose; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Methionine; Phenylenediamines; Thymidine; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1996 |
Efficacy of dinaline and its methyl and acetyl derivatives against colorectal cancer in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinogens; Colonic Neoplasms; Colorectal Neoplasms; Dimethylnitrosamine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Phenylenediamines; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1996 |
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Area Under Curve; Benzamides; Blood Cell Count; Bone Marrow; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Metabolic Clearance Rate; Mice; Phenylenediamines | 1997 |
Effectiveness of P-aminobenzoyl-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cells.
Topics: Animals; Colonic Neoplasms; Drug Evaluation, Preclinical; Female; Humans; Leukemia L1210; Lung Neoplasms; Mice; Neoplasms; Osteosarcoma; Ovarian Neoplasms; Phenylenediamines; Rats; Tumor Stem Cell Assay | 1985 |